መነሻ › የጋዜማ ገመድ ጡንቻ መኮማተር
በአሜሪካ ለየጋዜማ ገመድ ጡንቻ መኮማተር ተሳታፊዎችን እየፈለጉ ያሉ ክሊኒካዊ ጥናቶች
ለየጋዜማ ገመድ ጡንቻ መኮማተር የሚደረጉ 23 ጥናቶች በአሜሪካ ውስጥ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በጣም ብዙ ጥናቶች ያሏቸው ከተሞች
- Mountain View, CA9 ጥናቶች
- New York City, NY9 ጥናቶች
- Philadelphia, PA7 ጥናቶች
- Chicago, IL6 ጥናቶች
- Norfolk, VA6 ጥናቶች
- Grand Rapids, MI6 ጥናቶች
- Boston, MA5 ጥናቶች
- Houston, TX5 ጥናቶች
- Little Rock, AR4 ጥናቶች
- Lewisville, TX4 ጥናቶች
- Phoenix, AZ4 ጥናቶች
- Aurora, CO4 ጥናቶች
- Memphis, TN3 ጥናቶች
- Durham, NC3 ጥናቶች
- Cedar Rapids, IA3 ጥናቶች
- Orlando, FL3 ጥናቶች
- Columbia, MO3 ጥናቶች
- Portland, OR3 ጥናቶች
- Minneapolis, MN3 ጥናቶች
- Fort Worth, TX3 ጥናቶች
- Charlottesville, VA3 ጥናቶች
- Harrisburg, PA3 ጥናቶች
- Atlanta, GA3 ጥናቶች
- Gainesville, FL3 ጥናቶች
- Dallas, TX3 ጥናቶች
- Orange, CA3 ጥናቶች
በክልል
- New York10 ጥናቶች
- North Carolina3 ጥናቶች
- Oregon3 ጥናቶች
- Pennsylvania8 ጥናቶች
- Tennessee3 ጥናቶች
- Texas10 ጥናቶች
- Virginia7 ጥናቶች
- ሚሺጋን6 ጥናቶች
- ሚኔሶታ3 ጥናቶች
- ሚዙሪ4 ጥናቶች
- ማሳቹሴትስ6 ጥናቶች
- አሪዞና4 ጥናቶች
- አርካንሳስ4 ጥናቶች
- አዮዋ3 ጥናቶች
- ኢሊኖይ6 ጥናቶች
- ካሊፎርኒያ11 ጥናቶች
- ኮሎራዶ4 ጥናቶች
- ጆርጂያ3 ጥናቶች
- ፍሎሪዳ8 ጥናቶች
በቅርብ ጊዜ የተዘመኑ ጥናቶች
Official study text (English)
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
ተሳታዮችን በመፈለግ ላይደረጃ 4
3 Months – 24 Months · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05861986A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
ተሳታዮችን በመፈለግ ላይደረጃ 2
እስከ እድሜ 2 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07047144A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ15 እስከ 60 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07444476A Registry of Cases of Spinal Muscular Atrophy
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07805278ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ2 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT07448610A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ5 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT07287982A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
ተሳታዮችን በመፈለግ ላይደረጃ 4
3 Months – 24 Months · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT05861999A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 3 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06555419Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT07521930Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
ተሳታዮችን በመፈለግ ላይ
እድሜ 3 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT05866419A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
ተሳታዮችን በመፈለግ ላይደረጃ 3
0 Days – 42 Days · ሁሉም ጾታዎች · የተሻሻለው በ18 ኦገስ 2026 · NCT07221669A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
ተሳታዮችን በመፈለግ ላይደረጃ 3
0 Days – 7 Months · ሁሉም ጾታዎች · የተሻሻለው በ11 ኦገስ 2026 · NCT07444450Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ5 እስከ 20 · ሁሉም ጾታዎች · የተሻሻለው በ9 ጁላይ 2026 · NCT06532474Clinical Procedures to Support Research in ALS
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ጁን 2026 · NCT03489278ALS/MND Natural History Study Data Repository
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ20 ሜይ 2026 · NCT05966038Characterizing Perceived Physical Fatigability in Nusinersen-treated SMA
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሜይ 2026 · NCT06955897Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ 5 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ኤፕሪ 2026 · NCT06839469HABIT-ILE + FST in Children With SMA: Preliminary Effectiveness
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ5 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ23 ማርች 2026 · NCT07488338Gait and Bone Health in SMA
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ8 እስከ 50 · ሁሉም ጾታዎች · የተሻሻለው በ18 ማርች 2026 · NCT07400198Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ማርች 2026 · NCT07478172A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 54 · ሴቶች · የተሻሻለው በ9 ማርች 2026 · NCT05789758Diagnostic Journey, Patient Experience, and Disparities in the Treatment of Spinal Muscular Atrophy (SMA) in the MedStar Health System
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ጃንዩ 2026 · NCT07223489Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ31 ጃንዩ 2025 · NCT04174157ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።